| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 10/02/2008 | US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors |
| 10/02/2008 | US20080242677 improved pharmacological properties like metabolic stability, selectivity, bioavailability and activity; Liver-X-Receptors modulators; to treat increased lipid and cholesterol levels; 4-[4-(2,5-Dimethyl-phenyl)-piperazine-1-carbonyl]-1-(3-methoxy-benzenesulfonyl)-3-phenyl-imidazolidin-2-one |
| 10/02/2008 | US20080242676 Drug resistant Mycobacterium tuberculosis |
| 10/02/2008 | US20080242675 Prevent transplant rejection |
| 10/02/2008 | US20080242668 Neurodegenerative, inflammatory disorders, pain, drug abuse; useful as diagnostic tools or monitoring agents such as for neuroimaging, labelling; nicotinic and/or monoamine receptors modulators; 2,2'-Bis-((+-)-1-aza-bicyclo[2.2.2]oct-3-yloxy)-[5,5']-bithiazolyl; cholinergic ligands |
| 10/02/2008 | US20080242667 e.g. N-(4-{4-[2-({3-[2-(4-Morpholinyl)ethyl]phenyl}amino)-4-pyrimidinyl]-1H-pyrazol-3-yl}phenyl)benzamide; serine/threonine kinase inhibitor; anticarcinogenic, antitumor agent |
| 10/02/2008 | US20080242666 e.g. (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-(1-ethylpropyl)-1-[2(hydroxymethyl)benzyl]-piperazine-2,5-dione; preparation by cyclization |
| 10/02/2008 | US20080242662 substituted 3,4- or higher substituted piperazine compounds; renin inhibitor; antidiabetic, analgesic,hypotensive agent; neurodegenerative diseases; preparation by reacting a carbonic acid with amino compound |
| 10/02/2008 | US20080242658 Inhibitors of Iap |
| 10/02/2008 | US20080242653 Cyclopropyl amine derivatives |
| 10/02/2008 | US20080241955 Isobaric sets, mass differential labeling sets; mass spectrometry |
| 10/02/2008 | US20080241077 Benzoylguanidine salt and hydrates thereof |
| 10/02/2008 | CA2681431A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of .beta.-secretase |
| 10/02/2008 | CA2681034A1 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 10/01/2008 | EP1975142A1 Automated solid phase synthesis of pyrrole-imidazole polyamide |
| 10/01/2008 | EP1974608A1 Arylpyridazines as fungicides |
| 10/01/2008 | EP1973901A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 10/01/2008 | EP1973900A1 Hydantoin compounds for the treatment of inflammatory disorders |
| 10/01/2008 | EP1973899A2 Inhibitors of iap |
| 10/01/2008 | EP1973898A1 Pdf inhibitors |
| 10/01/2008 | EP1973886A2 Prokineticin 1 receptor antagonists |
| 10/01/2008 | EP1973884A2 Novel heterocycles |
| 10/01/2008 | EP1973548A2 Soft protease inhibitors and pro-soft forms thereof |
| 10/01/2008 | EP1732922B1 Methods for minimizing thioamide impurities |
| 10/01/2008 | EP1565456B1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 10/01/2008 | CN101277951A 2-aminopyrimidine derivatives as modulators of the histamine H4 receptor activity |
| 10/01/2008 | CN101277950A Inhibitors of serine proteases |
| 10/01/2008 | CN101277949A Dipeptidyl peptidase-iv inhibitors |
| 10/01/2008 | CN101277945A Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 10/01/2008 | CN101277934A Metabotropic glutamate-receptor-potentiating isoindolones |
| 10/01/2008 | CN101274932A 2-methyl-5- azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutive derivate, preparation thereof and application thereof |
| 10/01/2008 | CN100422176C Carbazole-containing compound and organic electroluminescence display device using the compound |
| 10/01/2008 | CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422171C Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 10/01/2008 | CN100421665C Mitotic kinesin inhibitors |
| 10/01/2008 | CA2654898A1 New chemical compounds |
| 09/30/2008 | US7429659 Isopropyl-piperazin-1-yl)-(5-piperidin-1-ylmethyl-furan-2-yl)-methanone; 5-(4-Fluoro-piperidin-1-ylmethyl)-furan-2-yl]-(4-isopropyl-piperazin-1-yl)-methanone, fumarate salt; insomnia, attention deficit hyperactivity disorders, learning disorders, cognitive dysfunction, eating disorders, obesity |
| 09/30/2008 | US7429611 Indole inhibitors of 15-lipoxygenase |
| 09/30/2008 | US7429609 Pyrazole compound and medicinal composition containing the same |
| 09/30/2008 | US7429607 5-HT2B receptor antagonists |
| 09/30/2008 | US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 09/30/2008 | US7429597 Heterobicyclic compound such as quinazoline anticoagulants and factor X inhibitors |
| 09/30/2008 | US7429593 Utilities of amide compounds |
| 09/30/2008 | US7429591 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(2-Amino-6-chloro-phenyl)-piperazin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 09/30/2008 | US7429590 e.g. 2-(4-Fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]-pyridine; protozoal diseases (toxoplasmosis, malaria, African typanosomiasis, Chagas disease, and opportunistic infections) in mammals and birds; controlling coccidiosis in poultry |
| 09/30/2008 | US7429579 antagonism/inhibition, of the D3 receptor; substance abuse. |
| 09/30/2008 | CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 09/30/2008 | CA2338220C Substituted imidazoles having cytokine inhibitory activity |
| 09/30/2008 | CA2314009C Triazole and imidazole derivatives |
| 09/25/2008 | WO2008116185A2 Substituted pyrimidines as adenosine receptor antagonists |
| 09/25/2008 | WO2008115516A2 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same |
| 09/25/2008 | WO2008115381A1 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/25/2008 | WO2008115141A1 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders |
| 09/25/2008 | WO2008114812A1 Jak inhibitor |
| 09/25/2008 | WO2008114023A2 Phthalazinone derivatives |
| 09/25/2008 | WO2008114002A1 Quinoline derivatives for the treatment of inflammatory diseases |
| 09/25/2008 | WO2008113795A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/25/2008 | WO2008113255A1 Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof |
| 09/25/2008 | WO2008075163A3 An improved process for the preparation of rizatriptan |
| 09/25/2008 | WO2008060391A3 2- [l-phenyl-5-hydr0xy-4alpha-methyl-hexahydr0cycl0penta[f] indaz0l-5-yl] ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 09/25/2008 | WO2008008854A3 Cxcr4 antagonists including diazine and triazine structures for the treatment of medical disorders |
| 09/25/2008 | WO2008008756A3 Herbicidal composition |
| 09/25/2008 | WO2007120655A3 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 09/25/2008 | US20080234495 Process for the Preparation of Almotriptan |
| 09/25/2008 | US20080234494 Indolylmaleimide Derivatives |
| 09/25/2008 | US20080234483 Fasudil-Containing Preparation and Method of Improving Stability Thereof |
| 09/25/2008 | US20080234355 Dna methyl transferase inhibitors containing a zinc binding moiety |
| 09/25/2008 | US20080234343 For oral administration, a transparent liquid mixture of an oily base, a surfactant, polar solvent, and an amount of a drug that is not very soluble in the solvent that exceeds its solubility in the solvent; dugs include 1,2,3,4-tetrahydro-1-benzazocine-5-carboxamide derivatives |
| 09/25/2008 | US20080234327 2-(benzo[d]thiazol-2-yl)-4,5-dihydro-2H-benzo[e]indazol-1-ol; hereditary hemochromatosis, anemias |
| 09/25/2008 | US20080234292 Such as S)-(1-(1-Aminobicyclo[2.2.2]oct-4-yl)aminoacetyl)-2-cyanopyrrolidine; inhibitors of the enzyme dipeptidyl peptidase; antidiabetic agents |
| 09/25/2008 | US20080234290 New indole or benzimidazole derivatives as cb1 inverse agonists |
| 09/25/2008 | US20080234289 Melanocortin Receptor-Specific Compounds |
| 09/25/2008 | US20080234278 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions |
| 09/25/2008 | US20080234273 Such as 3-{[4-(azetidin-1-ylcarbonyl)-2-chlorophenyl]oxy}-5-({(1S)-2-[(difluoromethyl)oxy]-1-methylethyl}oxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinases (Glk) |
| 09/25/2008 | US20080234270 For modulating activity of one or more steroid nuclear receptors and for treatment, prevention, or amelioration of symptoms of disease or disorder related to the activity of receptors; 5-benzo[b]thiophen-2-yl-1,4-dimethyl-1H-pyrrole-3-carboxylic acid (4-methanesulfonyl-phenyl)-amide |
| 09/25/2008 | US20080234266 Squaric Acid Derivatives II |
| 09/25/2008 | US20080234263 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide |
| 09/25/2008 | US20080234250 Heterocyclic Condensed Compounds Useful as Antidiuretic Agents |
| 09/25/2008 | US20080234223 5-azacytidine pyrimidine analog is epigenetic agent histone deacetylase inhibitor; inhibits nucleic acid methylation through an N4 carboxylester or ester bond; acetylcholine cell-targeting agent; cell expresses acetylcholinesterase; central nervous system; liver cancer |
| 09/25/2008 | US20080233601 Norbornenes are important monomers in ring-opening metathesis polymerizations; ELISAs that use the compounds and polymers as a chemiluminescent detection label |
| 09/25/2008 | CA2682195A1 Aminopyrimidines useful as kinase inhibitors |
| 09/25/2008 | CA2681633A1 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same |
| 09/25/2008 | CA2681516A1 Compounds useful as inhibitors of janus kinases |
| 09/25/2008 | CA2680761A1 Quinoline derivatives for the treatment of inflammatory diseases |
| 09/25/2008 | CA2680583A1 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/24/2008 | EP1972623A1 Arylpyridazines as fungicides |
| 09/24/2008 | EP1971601A2 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 09/24/2008 | EP1971597A2 N-(5-membered heteroaromatic ring)-amido anti-viral compounds |
| 09/24/2008 | EP1971596A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 09/24/2008 | EP1971595A2 Cetp inhibitors |
| 09/24/2008 | EP1971594A2 Substituted pyrazalones |
| 09/24/2008 | EP1971581A1 Piperazine compounds with a herbicidal action |
| 09/24/2008 | EP1971580A1 Piperazine compounds with a herbicidal action |
| 09/24/2008 | EP1971333A2 Amino acid derivatives of indolinone based protein kinase inhibitors |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | CN101273052A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273033A 4- (iH-indazol-s-yl-amino)-quinazoline compounds as ERBB receptor tyrosine kinase inhibitors for the treatment of cancer |
| 09/24/2008 | CN101273032A Pyrazine kinase inhibitors |
| 09/24/2008 | CN101273031A Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders |